1. Home
  2. CPF vs COLL Comparison

CPF vs COLL Comparison

Compare CPF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

N/A

Current Price

$35.81

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$22.10

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPF
COLL
Founded
1954
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
CPF
COLL
Price
$35.81
$22.10
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$43.00
★ $49.00
AVG Volume (30 Days)
113.0K
★ 751.9K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 3.34%
N/A
EPS Growth
★ 45.18
N/A
EPS
★ 1.58
N/A
Revenue
$51,817,000.00
★ $780,567,000.00
Revenue This Year
$4.11
$7.25
Revenue Next Year
$3.52
$1.55
P/E Ratio
$22.85
★ N/A
Revenue Growth
★ 33.81
23.62
52 Week Low
$27.40
$21.62
52 Week High
$40.99
$50.79

Technical Indicators

Market Signals
Indicator
CPF
COLL
Relative Strength Index (RSI) 30.20 30.33
Support Level $35.09 $21.65
Resistance Level $39.59 $23.69
Average True Range (ATR) 0.74 0.87
MACD -0.15 0.24
Stochastic Oscillator 0.00 17.87

Price Performance

Historical Comparison
CPF
COLL

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: